Usana Health Sciences
USNA
130 hedge funds and large institutions have $542M invested in Usana Health Sciences in 2013 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 43 increasing their positions, 51 reducing their positions, and 19 closing their positions.
0.22% more ownership
Funds ownership: 103.06% → 103.28% (+0.22%)
6% less funds holding
Funds holding: 139 → 130 (-9)
12% less capital invested
Capital invested by funds: $616M → $542M (-$74.2M)
16% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 51
47% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$5.44M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$4.87M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$3.18M |
| 4 |
JP Morgan Chase
New York
|
+$2.82M |
| 5 |
U
UBS
Zurich,
Switzerland
|
+$2.64M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LSV Asset Management
Chicago,
Illinois
|
-$4.66M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$3.53M |
| 3 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$3.37M |
| 4 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
-$2.67M |
| 5 |
ARC
Absolute Return Capital
Boston,
Massachusetts
|
-$2.31M |
USNA Hedge Fund Activity: Q4 2013 in Review
130 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q4 2013, worth a combined $542M — down 12% from $616M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of USNA and 10 opened new positions — a net loss of 9 holders — while 51 trimmed existing stakes and 43 added.
The largest buyer was Renaissance Technologies, adding an estimated $5.44M. The largest seller was LSV Asset Management, cutting an estimated $4.66M.
- 130 institutional investors held Usana Health Sciences (USNA) as of Q4 2013, down from 139 in Q3 2013.
- Funds reported $542M of Usana Health Sciences stock for Q4 2013, down 12% quarter-over-quarter.
- 10 funds opened new Usana Health Sciences positions in Q4 2013 and 19 closed out, a net change of -9 holders.
- The largest Usana Health Sciences buyer in Q4 2013 was Renaissance Technologies, an estimated $5.44M added.
- The largest Usana Health Sciences seller in Q4 2013 was LSV Asset Management, an estimated $4.66M sold.
Based on aggregated 13F filings for Q4 2013.